Skip to main content

07.05.2024 | New and Emerging Therapies in Interventional Pain Medicine (J Hasoon, Section Editor)

Can Long-Term Outcomes of Posttraumatic Headache be Predicted?

verfasst von: Olivia Kingsford, Mustafa Yehya, Glynnis Zieman, Kerry L. Knievel

Erschienen in: Current Pain and Headache Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Headache is one of the most common symptoms of traumatic brain injury, and it is more common in patients with mild, rather than moderate or severe, traumatic brain injury. Posttraumatic headache can be the most persistent symptom of traumatic brain injury. In this article, we review the current understanding of posttraumatic headache, summarize the current knowledge of its pathophysiology and treatment, and review the research regarding predictors of long-term outcomes.

Recent Findings

To date, posttraumatic headache has been treated based on the semiology of the primary headache disorder that it most resembles, but the pathophysiology is likely to be different, and the long-term prognosis differs as well. No models exist to predict long-term outcomes, and few studies have highlighted risk factors for the development of acute and persistent posttraumatic headaches. Further research is needed to elucidate the pathophysiology and identify specific treatments for posttraumatic headache to be able to predict long-term outcomes. In addition, the effect of managing comorbid traumatic brain injury symptoms on posttraumatic headache management should be further studied.

Summary

Posttraumatic headache can be a persistent symptom of traumatic brain injury, especially mild traumatic brain injury. It has traditionally been treated based on the semiology of the primary headache disorder it most closely resembles, but further research is needed to elucidate the pathophysiology of posttraumatic headache and determine risk factors to better predict long-term outcomes.
Literatur
3.
Zurück zum Zitat Centers for Disease Control and Prevention. CDC grand rounds: reducing severe traumatic brain injury in the United States. MMWR Morb Mortal Wkly Rep. 2013;62:549–52. Centers for Disease Control and Prevention. CDC grand rounds: reducing severe traumatic brain injury in the United States. MMWR Morb Mortal Wkly Rep. 2013;62:549–52.
8.
Zurück zum Zitat Shaikh F, Waseem M. Head Trauma. StatPearls Publishing, 2023. Shaikh F, Waseem M. Head Trauma. StatPearls Publishing, 2023.
9.
Zurück zum Zitat Eapen BC, Cifu DX. Brain Injury Medicine Board Review. Elsevier, 2020. Eapen BC, Cifu DX. Brain Injury Medicine Board Review. Elsevier, 2020.
46.
Zurück zum Zitat Uomoto JM, Esselman PC. Traumatic brain injury and chronic pain: differential types and rates by head injury severity. Arch Phys Med Rehabil. 1993;74:61–4.PubMed Uomoto JM, Esselman PC. Traumatic brain injury and chronic pain: differential types and rates by head injury severity. Arch Phys Med Rehabil. 1993;74:61–4.PubMed
55.
Zurück zum Zitat Howard L, Dumkrieger G, Chong CD, Ross K, Berisha V, Schwedt TJ. Symptoms of autonomic dysfunction among those with persistent posttraumatic headache attributed to mild traumatic brain injury: a comparison to migraine and healthy controls. Headache. 2018;58:1397–407. https://doi.org/10.1111/head.13396.CrossRefPubMed Howard L, Dumkrieger G, Chong CD, Ross K, Berisha V, Schwedt TJ. Symptoms of autonomic dysfunction among those with persistent posttraumatic headache attributed to mild traumatic brain injury: a comparison to migraine and healthy controls. Headache. 2018;58:1397–407. https://​doi.​org/​10.​1111/​head.​13396.CrossRefPubMed
64.
Zurück zum Zitat DePalma RG. Combat TBI: history, epidemiology, and injury modes. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Kobeissy FH (ed): CRC Press/Taylor & Francis, Boca Raton (FL); 2015. DePalma RG. Combat TBI: history, epidemiology, and injury modes. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Kobeissy FH (ed): CRC Press/Taylor & Francis, Boca Raton (FL); 2015.
78.
Zurück zum Zitat Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett. 2004;25:31–9.PubMed Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett. 2004;25:31–9.PubMed
87.
Zurück zum Zitat Toth A. Magnetic resonance imaging application in the area of mild and acute traumatic brain injury: implications for diagnostic markers? Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Kobeissy FH (ed): CRC, Boca Raton (FL); 2015. Toth A. Magnetic resonance imaging application in the area of mild and acute traumatic brain injury: implications for diagnostic markers? Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Kobeissy FH (ed): CRC, Boca Raton (FL); 2015.
91.
Zurück zum Zitat • Andersen AM, Ashina H, Iljazi A, et al. Risk factors for the development of post-traumatic headache attributed to traumatic brain injury: a systematic review. Headache. 2020;60:1066–75. https://doi.org/10.1111/head.13812. This article reviews work to date on risk factors for persistent posttraumatic headache and highlights the need for further research on this topic.CrossRefPubMed • Andersen AM, Ashina H, Iljazi A, et al. Risk factors for the development of post-traumatic headache attributed to traumatic brain injury: a systematic review. Headache. 2020;60:1066–75. https://​doi.​org/​10.​1111/​head.​13812. This article reviews work to date on risk factors for persistent posttraumatic headache and highlights the need for further research on this topic.CrossRefPubMed
Metadaten
Titel
Can Long-Term Outcomes of Posttraumatic Headache be Predicted?
verfasst von
Olivia Kingsford
Mustafa Yehya
Glynnis Zieman
Kerry L. Knievel
Publikationsdatum
07.05.2024
Verlag
Springer US
Erschienen in
Current Pain and Headache Reports
Print ISSN: 1531-3433
Elektronische ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-024-01254-2

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.